Update from Novo Nordisk regarding its share repurchase programme

On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 2.4 billion in the period from 10 August 2009 to 18 December 2009.

Since the announcement as of 26 October 2009, the following transactions have been made under the programme:

Number of Average Transaction value, shares purchase price DKK Accumulated, last announcement 4,222,050 1,347,733,822 26 October 2009 52,950 323.8990 17,150,452 27 October 2009 77,500 324.4390 25,144,023 28 October 2009 75,000 327.1799 24,538,493 29 October 2009 151,599 314.7490 47,715,634 30 October 2009 90,000 313.7299 28,235,691 Accumulated under the programme 4,669,099 1,490,518,113

Transactions related to Novo Nordisk's incentive programmes have resulted in a net sale by Novo Nordisk of 29,080 B shares in the period from 29 October 2009 to 30 October 2009. The shares in these transactions were not part of the Safe Harbour repurchase programme.

With the transactions stated above, Novo Nordisk owns a total of 29,476,827 treasury shares, corresponding to 4.8% of the share capital. The total amount of shares in the company is 620,000,000 including treasury shares.


Novo Nordisk A/S



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
New research program receives DKK 100 million in funding from Novo Nordisk Foundation